Pancreatic Cancer Research

ResearcherHarvard UniversityNo recent work listed

Jennifer Ann Wargo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3438-7576; OpenAlex author ID A5035427219. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
42
Papers, trials and grants by year

2012: 3 papers · 2013: 3 papers · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 3 papers · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 10

  1. From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer. First author DOI 10.1016/j.xcrm.2023.101039↗
  2. The Tumor Microbiome in Pancreatic Cancer: Bacteria and Beyond. Last author DOI 10.1016/j.ccell.2019.11.004↗
  3. Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes. Co-author DOI 10.1016/j.cell.2019.07.008↗
  4. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Co-author DOI 10.1073/pnas.1811067116↗
  5. N0/N1, PNL, or LNR? The effect of lymph node number on accurate survival prediction in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s11605-012-1974-7↗
  6. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection? Co-author DOI 10.1097/sla.0b013e318263da2f↗
  7. FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience. Co-author DOI 10.1634/theoncologist.2012-0435↗
  8. Intraductal papillary mucinous neoplasms: does a family history of pancreatic cancer matter? Co-author DOI 10.1016/j.pan.2012.05.011↗
  9. Pancreatic ductal adenocarcinoma: long-term survival does not equal cure. Co-author DOI 10.1016/j.surg.2012.05.020↗
  10. Targeting the MAGE A3 antigen in pancreatic cancer. Last author DOI 10.1016/j.surg.2012.05.031↗

Closest collaborators

The 25 strongest of 42 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongwoo David Seo · 1 shared paper, 2023 · strength 0.39
  2. Florencia M. McAllister · 2 shared papers, 2019 · strength 0.20
  3. Cristina Rosa Ferrone · 6 shared papers, 2012–2013 · strength 0.18
  4. Andrew Louis Warshaw · 5 shared papers, 2012–2013 · strength 0.15
  5. Sarah P. Thayer · 5 shared papers, 2012–2013 · strength 0.15
  6. Matthew H. G. Katz · 2 shared papers, 2019 · strength 0.13
  7. Anirban Maitra · 2 shared papers, 2019 · strength 0.13
  8. Carlos F. Fernandez-del Castillo · 4 shared papers, 2012–2013 · strength 0.12
  9. Keith D. Lillemoe · 4 shared papers, 2012–2013 · strength 0.12
  10. Michael James Overman · 1 shared paper, 2019 · strength 0.07
  11. Chantale Bernatchez · 1 shared paper, 2019 · strength 0.07
  12. Huamin Wang · 1 shared paper, 2019 · strength 0.07
  13. Jorge M. Blando · 1 shared paper, 2019 · strength 0.07
  14. Padmanee Sharma · 1 shared paper, 2019 · strength 0.07
  15. Cassian Yee · 1 shared paper, 2019 · strength 0.07
  16. Gauri Rajani Varadhachary · 1 shared paper, 2019 · strength 0.07
  17. Christine A. Iacobuzio–Donahue · 1 shared paper, 2019 · strength 0.07
  18. Paul A Scheet · 1 shared paper, 2019 · strength 0.06
  19. Erick Marcelo Riquelme Sanchez · 1 shared paper, 2019 · strength 0.06
  20. Christine B. Peterson · 1 shared paper, 2019 · strength 0.06
  21. Vidhi Chandra · 1 shared paper, 2019 · strength 0.06
  22. Laura DeLong Wood · 1 shared paper, 2019 · strength 0.06
  23. Michael P. Kim · 1 shared paper, 2019 · strength 0.06
  24. Samir Hanash · 1 shared paper, 2019 · strength 0.06
  25. Ching-Wei David Tzeng · 1 shared paper, 2019 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.